| Bioactivity | THRX-195518 is the major metabolite of Revefenacin (HY-15851), a lung-selective and long-acting muscarinic antagonist. THRX-195518 can be utilized in research related to chronic obstructive pulmonary disease[1]. |
| CAS | 909800-36-8 |
| Formula | C35H42N4O5 |
| Molar Mass | 598.73 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lo A, et al. Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease. Clin Pharmacokinet. 2021 Mar;60(3):391-401. |
THRX-195518
CAS: 909800-36-8 F: C35H42N4O5 W: 598.73
THRX-195518 is the major metabolite of Revefenacin (HY-15851), a lung-selective and long-acting muscarinic antagonist. T
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.